Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

BI8622

BI8622 is a specific inhibitor of the ubiquitin ligase HUWE1 with an IC50 of 3.1 μM. BI8622 can decrease the protein expression levels of c-myc and glycolytic markers as well as immune modulatory markers after HUWE1 inhibition in triple-negative breast cancer (TNBC) cell lines. BI8622 significantly protects against cisplatin -induced acute kidney injury (AKI). BI8622 significantly reduces the growth of multiple myeloma (MM) cell lines and induces cell cycle arrest. BI8622 can prevent HUWE1-dependent TTBK2 ubiquitination. BI8622 can be studied in research for various diseases including medulloblastoma, acute kidney injury, breast cancer and MM[1][2][3][4][5].

Product Specifications

CAS Number

1875036-74-0

UNSPSC

12352005

Target

C-Myc; E1/E2/E3 Enzyme

Type

Reference compound

Related Pathways

Apoptosis; Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/bi8622.html

Purity

99.35

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C(C1=NC=NC(N2CCC(C3=CC=CC=C3)(C#N)CC2)=C1C)NC4=CC=C(CN)C=C4

Molecular Formula

C25H26N6O

Molecular Weight

426.51

References & Citations

[1]Peter S, et al. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol Med. 2014 Dec;6 (12) :1525-41.|[2]S. Kahol and S. Mathur (2023) 29P HUWE1 inhibition has tumor suppressive effect in triple-negative breast cancer cell lines by modulating glycolytic and immune modulatory markers. Annals of oncology, Volume 34, Supplement 4S1484.|[3]Crawford, L. J., et al., (2020) . The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma. Oncogene, 39 (27), 5001–5014.|[4]Yang, Y., et al., (2025) . HUWE1-Mediated Degradation of MUTYH Facilitates DNA Damage and Mitochondrial Dysfunction to Promote Acute Kidney Injury. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12 (13), e2412250|[5]Lin, I. H., et al., (2024) . Regulation of primary cilia disassembly through HUWE1-mediated TTBK2 degradation plays a crucial role in cerebellar development and medulloblastoma growth. Cell death and differentiation, 31 (10), 1349–1361.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Amyloid β-Protein (1-43)
4018358.0500 0.5 mg

Amyloid β-Protein (1-43)

Sign In for Pricing
View Details
PGLYRP3 Antibody
orb309498 100 µL

PGLYRP3 Antibody

Sign In for Pricing
View Details
KRT16 Antibody
orb1245654 100 µL

KRT16 Antibody

Sign In for Pricing
View Details
HRP Linked Monoclonal Antibody to Receptor Interacting Serine Threonine Kinase 3 (RIPK3)
MBS2136495-01 0.1 mL

HRP Linked Monoclonal Antibody to Receptor Interacting Serine Threonine Kinase 3 (RIPK3)

Sign In for Pricing
View Details
HRP Linked Monoclonal Antibody to Receptor Interacting Serine Threonine Kinase 3 (RIPK3)
MBS2136495-02 0.2 mL

HRP Linked Monoclonal Antibody to Receptor Interacting Serine Threonine Kinase 3 (RIPK3)

Sign In for Pricing
View Details
HRP Linked Monoclonal Antibody to Receptor Interacting Serine Threonine Kinase 3 (RIPK3)
MBS2136495-03 0.5 mL

HRP Linked Monoclonal Antibody to Receptor Interacting Serine Threonine Kinase 3 (RIPK3)

Sign In for Pricing
View Details